| Date | Title | Description |
| 03.03.2026 | Diversity will define the next era of biotech infrastructure | - |
| 10.09.2025 | Ridge Biotechnologies Raises $25M in Seed Financing | Ridge Biotechnologies, a Palo Alto, CA-based company providing an enzyme and targeted drug design to improve the precision medicines, raised $25M in Seed funding.
The round was led by Sutter Hill Ventures (SHV) with participation from Overl... |
| 24.02.2025 | Greek Co-Founded Achira Secures €31.54M with NVIDIA’s Backing | Company:
Greek co-founded Achira, a startup combining AI and physics-based methods for drug discovery, secured a €31.54 million seed round from Dimension, Amplify Partners, Compound, and NVentures (NVIDIA’s VC arm).
👯 Founders: John Chodera... |
| 05.11.2021 | Contributed: Improving healthcare productivity with automation and opportunities for startups | Photo: Me789 Studio/Getty Images |
| 30.06.2021 | COVID-19 as an accelerator of digital healthcare development: investments, trends, perspectives | COVID-19 as an accelerator of digital healthcare development: investments, trends, perspectives |
| 30.06.2021 | COVID-19 как акселератор развития цифровой медицины: инвестиции, тренды, перспективы | COVID-19 как акселератор развития цифровой медицины: инвестиции, тренды, перспективы |
| 17.03.2021 | ML-driven drug discovery company Insitro raises US$ 400M | US-based Insitro, a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery, raised US$ 400M in a Series C funding round on 15 March 2021. |
| 16.03.2021 | Insitro picks up $400M for drug development | Insitro has raised a $400 million Series C led by Canada Pension Plan Investment Board, with participation from investors including Andreessen Horowitz, Casdin Capital, HOF Capital, Two Sigma Ventures, Temasek and Arch Venture Partners. The... |
| 15.03.2021 | Daily funding roundup - March 15th, 2021 | Stripe landed $600M; ElevateBio raised $525M; Graphite Bio secured $150M
Airtable: Airtable is a San Francisco-based no-code relational database that has amassed a customer base that spans 250,000 different organizations. Airtable just clos... |
| 15.03.2021 | Insitro raises $400M for machine learning-powered drug discovery efforts | The artificial intelligence-powered drug discovery company insitro has secured a mammoth funding round of $400 million, to carry forward its development efforts and Big Pharma partnerships with the likes of Gilead and Bristol Myers Squibb.
... |
| 15.03.2021 | insitro : Raises $400 Million in Series C Financing | insitro, a machine learning-driven drug discovery and development company, today announced that it has raised $400 million in a Series C financing. The financing was led by Canada Pension Plan Investment Board (CPP Investments), with signif... |
| 15.03.2021 | Insitro raises $400M for machine learning-powered drug discovery efforts | The artificial intelligence-powered drug discovery company insitro has secured a mammoth funding round of $400 million, to carry forward its development efforts and Big Pharma partnerships with the likes of Gilead and Bristol Myers Squibb.
... |
| 15.03.2021 | Insitro Raises $400M in Series C |
SOUTH SAN FRANCISCO, CA, Insitro has raised $400 million in a Series C financing led by Canada Pension Plan Investment Board.
>> Click here for more funding data on Insitro
>> To export Insitro funding data to PDF and Excel,... |
| 16.09.2020 | Daphne Koller: ‘Digital biology is an incredible place to be right now’ | Working at the intersection of biology and computing may be the most exciting new spot for technologists at the moment.
That’s the word from Daphne Koller, the founder and chief executive officer of Insitro — the biotech company that’s rais... |
| 28.05.2020 | Drug Discovery Company insitro Raises $143 Million | insitro, a machine-learning driven drug discovery and development company, announced it raised $143 million in an oversubscribed Series B financing
insitro — a machine-learning driven drug discovery and development company — announced it ha... |
| 26.05.2020 | insitro Raises $143M in Series B Financing | insitro, a San Francisco, CA-based machine-learning driven drug discovery and development company, raised $143m in Series B financing.
The round was led by Andreessen Horowitz, with participation from new investors Canada Pension Plan Inves... |
| 26.05.2020 | Insitro nets $143M to ramp up machine learning drug discovery
W h i t e p a p e r
Weighing the Costs: | In the two years since it set up shop, insitro has been plugging away at a data- and machine learning-driven approach to drug discovery. Now, the company is picking up $143 million to build out its technology, pursue new targets and advance... |
| 26.05.2020 | Insitro nets $143M to ramp up machine learning drug discovery | In the two years since it set up shop, insitro has been plugging away at a data- and machine learning-driven approach to drug discovery. Now, the company is picking up $143 million to build out its technology, pursue new targets and advance... |
| 26.05.2020 | insitro : Announces $143 Million Raised in Series B Financing | insitro, a machine-learning driven drug discovery and development company, today announced that it has raised $143 million in an oversubscribed Series B financing. The financing was led by Andreessen Horowitz, with participation from new in... |
| 09.08.2019 | Biotech researchers venture into the wild to start their own business | Jorge Conde Contributor
Share on Twitter
Jorge Conde is a General Partner at Andreessen Horowitz where he leads investments at the cross section of biology, computer science and engineering.
Much of Silicon Valley mythology is centered on t... |
| 31.05.2019 | Groupon co-founder Eric Lefkofsky just raised another $200 million for his newest company, Tempus | When serial entrepreneur Eric Lefkofsky grows a company, he puts the pedal to the metal. When in 2011 his last company, the Chicago-based coupons site Groupon, raised $950 million from investors, it was the largest amount raised by a startu... |
| 21.05.2019 | Famed founder Daphne Koller tells it straight: ‘With most drugs, we do not understand why they work’ | Daphne Koller doesn’t mind hard work. She joined Stanford University’s computer science department in 1995, spending the next 18 years there in a full-time capacity before co-founding the online education giant Coursera, where she spent the... |
| 16.04.2019 | In a test for AI, a buzzy machine learning startup inks drug discovery deal with Gilead | SAN FRANCISCO — It took only a single, one-hour meeting in a Starbucks to convince venture capitalist Robert Nelsen that he was going to invest in the company being built by machine-learning whiz Daphne Koller. “She’s just an amazing force ... |
| 16.04.2019 | Gilead, Insitro in $250M machine learning partnership to develop NASH drugs | NASH is a form of fatty liver disease incidental to obesity and Type 2 diabetes. It is on the rise around the world and is expected by many analysts to represent a market that will explode in value over the next few years, but as yet has no... |
| 29.03.2019 | Чем занимаются ведущие учёные в сфере искусственного интеллекта и какие работы принесли им славу Статьи редакции... | Технологии «умных» пространств, беспилотный транспорт и устройство для распознавания лягушачьего кваканья.
21 21 комментарий
28 216 просмотров
Слушать
В основе списка — анализ рейтингов рекрутинговой компании по поиску талантливых учёных Le... |
| 19.10.2018 | Regina Dugan: Companies using AI should consider worst-case scenarios | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Former DARPA director and leader of secretive sku... |
| 19.10.2018 | Regina Dugan: Companies using AI should consider worst-case scenarios | Former DARPA director and leader of secretive skunkworks divisions at Facebook and Google Regina Dugan said companies need to think about how using AI technology can go wrong in order to try to understand the ethical, societal, and legal im... |
| 05.05.2018 | AI researcher from Alphabet’s Calico Labs launches startup applying machine learning to drug discovery | To enable the machine learning, we will use high-quality data that has already been collected, but we will also invest heavily in the creation of our own datasets using high throughput experimental approaches, datasets that are designed exp... |
| 05.05.2018 | A life sciences firm run by a top VC and a cofounder of Alphabet’s life sciences arm, just raised its biggest fund yet | There’s no end to the number of fascinating devices and therapies being created right now in the fields of health and life sciences. The investors behind them are often pretty interesting, too, given the expertise needed to make informed be... |
| 02.05.2018 | Out to ‘rethink the drug design process,’ AI star Daphne Koller is creating a new machine learning venture at insitro with some heavyweight backers | Daphne Koller has been busy.
Just two months since the high profile AI expert exited Google’s anti-aging biotech Calico Labs, where she was chief computing officer, Koller has gathered a group of marquee investors to back a t... |
| 02.05.2018 | insitro: Rethinking drug discovery using machine learning | - |
| - | Biotech startup with AlphaGo-type AI approach snags $30M | In the world of artificial intelligence and machine learning, Google Deepmind’s AlphaGo program defeating world champion Lee Sedol at the game Go on March 19, 2016, was a watershed moment. It showed, among other things, that if an AI algori... |
| - | AI researcher from Alphabet’s Calico Labs launches startup applying machine learning to drug discovery | A former Stanford University researcher who served as chief computing officer at Alphabet anti-aging business Calico Labs has launched a startup of her own. In a Medium blog post, Daphne Koller offered an overview of her new business, insit... |
| - | Gilead, Insitro in $250M machine learning partnership to develop NASH drugs | A large biotech company has made a deal with a smaller firm to incorporate a new weapon into its arsenal against nonalcoholic steatohepatitis: machine learning.
Foster City, California-based Gilead Sciences said Tuesday that it had partnere... |
| - | VCs just poured $5.4 billion into startups forging the future of healthcare. Here are the 11 top digital health startups that took home the most cash. | Naomi Hassebroek holds her son Felix while working with her husband Doug Hassebroek at their home, after public schools closed in New York due to coronavirus in March 2020. REUTERS/Caitlin Ochs This story is available exclusively to Insider... |
| - | insitro Raises $400 Million in Series C Financing | SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Mar 15, 2021--
insitro, a machine learning-driven drug discovery and development company, today announced that it has raised $400 million in a Series C financing. The financing was led by Canada Pension... |
| - | Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity | The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response. Within the Health IT industry, the already strong investment and M&am... |
